What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy on the expression of inflammatory factors in keloid tissues by comparing 30 samples from keloid patients treated with HBO, keloid patients without HBO, and normal skin controls.
What They Found
They found significantly different expression levels of inflammatory mediators (IL-12p40, MIP-1β, PDGF-BB, and IL-1Ra) in keloid tissues compared to normal skin. Significant differences in these expression levels were also observed among the three groups of 10 samples each (HBO-treated keloids, non-HBO keloids, and normal skin).
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a new approach to manage keloids by modulating inflammatory factors, potentially leading to improved treatment outcomes. Patients with keloids might benefit from further research into HBO as a therapeutic option to reduce inflammation and scarring.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is its relatively small sample size of 30 tissue samples.